Finally, there are mechanisms of action of these GLP-1s that we don't completely understand." The study is titled, "GLP1 Receptor Agonists and the Risk of Significant Hypotension Among Patients with Metabolic Cardiovascular Renal Disease: Too Much of A Good Thing?"
As a result, some patients go online to find these popular medications
If patients have achieved 50% reduction in LDL-C from baseline and LDL-C 75 years, diabetes, stroke, coronary artery bypass graft, PAD, eGFR 20% reduction in LDL-C
Patients not only lose weight but also lower their risk of serious conditions like type 2 diabetes , high blood pressure , and heart disease
If this is an area youre navigating, Id love to hear your thoughts
Dong Y, et al